This study is currently not recruiting participants.

A 3-Month Multi-Center Double-Masked Safety and Efficacy Study of Travoprost Ophthalmic Solution 0.004% Compared to Timolol(0.5% or 0.25%) in Pediatric Glaucoma Patients

Investigating the Effectiveness of Eye Solutions in Lowering Eye Pressure in Children with Glaucoma

Not Recruiting
1 years - 18 years
All
Phase N/A

Brief description of study.

The purpose of this research study is to compare the pressure lowering ability of Travoprost Ophthalmic Solution to Timolol Ophthalmic Solution in pediatric patients with glaucoma.

Detailed description of study

The purpose of this research study is to compare the pressure lowering ability of Travoprost Ophthalmic Solution to Timolol Ophthalmic Solution in pediatric patients with glaucoma.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Glaucoma
  • Age: 1 years - 18 years
  • Gender: All

This study investigates the effectiveness of two different eye solutions in lowering eye pressure in children with glaucoma. Glaucoma is a condition that damages the eye's optic nerve and can lead to vision loss. The study aims to compare the effects of an investigational medication to another commonly used eye solution.

Participants will receive either the investigational medication or the other eye solution. The study will involve regular eye check-ups to monitor the eye pressure and assess the effectiveness of the treatment. No invasive procedures are involved.

  • Who can participate: Children aged 5 to 12 diagnosed with glaucoma are eligible to participate in this study. Participants must be able to attend regular eye check-ups.
  • Study details: Participants will be randomly assigned to receive either the investigational medication or the other eye solution. No placebo will be used. Regular eye check-ups will be conducted to monitor eye pressure and treatment effectiveness.
Updated on 19 Feb 2024. Study ID: 1207009232

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team